Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Pre-hospital Use of a Valsalva Assist Devise (VAD) in the Emergency Treatment of Supraventricular Tachycardia (SVT). A Randomised Controlled Feasibility Trial [EVADE]

NCT03514628 is registered in ClinicalTrials.gov with South Western Ambulance Service NHS Foundation Trust as lead sponsor.

NCT NCT03514628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03514628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Pre-hospital Use of a Valsalva Assist Devise (VAD) in the Emergency Treatment of Supraventricular Tachycardia (SVT). A Randomised Controlled Feasibility Trial [EVADE]
Lead sponsor
South Western Ambulance Service NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2018
Completion date
December 31, 2018
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emergencies, svt, vagal bradycardia